ROBERTS EIRY has filed 76 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 20414 shares of AMICUS THERAPEUTICS, INC. ($FOLD) on June 05, 2025.
Activity breakdown: 0 open-market purchases and 26 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 5, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | ROBERTS EIRY | Not found | A | Common Stock | 20414 | $0.00 | 76,275.0000 | 300,116,081 | 36.54% | 0.01% |
| June 5, 2025 | AMICUS THERAPEUTICS, INC. | $FOLD | ROBERTS EIRY | Not found | A | Stock Options (right to buy) | 74872 | $0.00 | 74,872.0000 | 300,116,081 | 9999.99% | 0.02% |
| Feb. 13, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 1372 | $0.00 | 36,140.0000 | 103,700,000 | 3.95% | 0.00% |
| Feb. 14, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 500 | $115.04 | 35,640.0000 | 103,700,000 | 1.38% | 0.00% |
| Feb. 12, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | A | Stock Option | 43261 | $0.00 | 43,261.0000 | 103,700,000 | 9999.99% | 0.04% |
| Feb. 12, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | A | Restricted Stock Unit | 8108 | $0.00 | 8,108.0000 | 103,700,000 | 9999.99% | 0.01% |
| Feb. 13, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Restricted Stock Unit | 2113 | $0.00 | 4,227.0000 | 103,700,000 | 33.33% | 0.00% |
| Feb. 13, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Restricted Stock Unit | 1120 | $0.00 | 3,363.0000 | 103,700,000 | 24.98% | 0.00% |
| Feb. 13, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Restricted Stock Unit | 1372 | $0.00 | 4,115.0000 | 103,700,000 | 25.00% | 0.00% |
| Feb. 13, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 1114 | $116.90 | 34,252.0000 | 103,700,000 | 3.15% | 0.00% |
| Feb. 13, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 604 | $116.74 | 34,768.0000 | 103,700,000 | 1.71% | 0.00% |
| Feb. 13, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 2113 | $0.00 | 35,366.0000 | 103,700,000 | 6.35% | 0.00% |
| Feb. 13, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 1120 | $0.00 | 35,372.0000 | 103,700,000 | 3.27% | 0.00% |
| Feb. 8, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Restricted Stock Unit | 1860 | $0.00 | 0.0000 | 103,700,000 | 100.00% | 0.00% |
| Feb. 8, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 1860 | $0.00 | 34,233.0000 | 103,700,000 | 5.75% | 0.00% |
| Feb. 10, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 980 | $118.22 | 33,253.0000 | 103,700,000 | 2.86% | 0.00% |
| Jan. 31, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Restricted Stock Unit | 2769 | $0.00 | 2,769.0000 | 103,700,000 | 50.00% | 0.00% |
| Jan. 31, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 2769 | $0.00 | 33,830.0000 | 103,700,000 | 8.91% | 0.00% |
| Jan. 31, 2025 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 1457 | $152.80 | 32,373.0000 | 103,700,000 | 4.31% | 0.00% |
| Dec. 17, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | A | Restricted Stock Unit | 5487 | $0.00 | 5,487.0000 | 104,300,000 | 9999.99% | 0.01% |
| Dec. 17, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | A | Stock Option | 27770 | $0.00 | 27,770.0000 | 104,300,000 | 9999.99% | 0.03% |
| Nov. 8, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 5140 | $77.81 | 28,856.0000 | 104,300,000 | 21.67% | 0.00% |
| Nov. 8, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 1233 | $81.05 | 30,089.0000 | 104,300,000 | 4.27% | 0.00% |
| Nov. 8, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 971 | $102.90 | 31,060.0000 | 104,300,000 | 3.23% | 0.00% |
| Nov. 8, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 1 | $79.02 | 31,061.0000 | 104,300,000 | 0.00% | 0.00% |
| Nov. 8, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Incentive Stock Option | 5140 | $0.00 | 0.0000 | 104,300,000 | 100.00% | 0.00% |
| Nov. 8, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Incentive Stock Option | 1233 | $0.00 | 0.0000 | 104,300,000 | 100.00% | 0.00% |
| Nov. 8, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Incentive Stock Option | 971 | $0.00 | 0.0000 | 104,300,000 | 100.00% | 0.00% |
| Nov. 8, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Incentive Stock Option | 1 | $0.00 | 1,265.0000 | 104,300,000 | 0.08% | 0.00% |
| June 6, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | ROBERTS EIRY | Not found | A | Common Stock | 11847 | $0.00 | 55,861.0000 | 295,164,515 | 26.92% | 0.00% |
| June 6, 2024 | AMICUS THERAPEUTICS, INC. | $FOLD | ROBERTS EIRY | Not found | A | Stock Options (right to buy) | 42467 | $0.00 | 42,467.0000 | 295,164,515 | 9999.99% | 0.01% |
| Feb. 13, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | A | Restricted Stock Unit | 4483 | $0.00 | 4,483.0000 | 101,000,000 | 9999.99% | 0.00% |
| Feb. 13, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | A | Stock Option | 22529 | $0.00 | 22,529.0000 | 101,000,000 | 9999.99% | 0.02% |
| Feb. 13, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 1114 | $132.96 | 23,716.0000 | 101,000,000 | 4.49% | 0.00% |
| Feb. 8, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 980 | $134.21 | 22,717.0000 | 101,000,000 | 4.14% | 0.00% |
| Feb. 6, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 1121 | $142.24 | 21,837.0000 | 101,000,000 | 4.88% | 0.00% |
| Jan. 31, 2024 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 1457 | $140.79 | 20,832.0000 | 101,000,000 | 6.54% | 0.00% |
| Dec. 22, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 10000 | $126.74 | 19,521.0000 | 98,900,000 | 33.87% | 0.01% |
| Dec. 12, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 6978 | $81.05 | 36,499.0000 | 98,900,000 | 23.64% | 0.01% |
| Dec. 12, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 6978 | $120.30 | 29,521.0000 | 98,900,000 | 19.12% | 0.01% |
| Dec. 12, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 6947 | $81.05 | 36,468.0000 | 98,900,000 | 23.53% | 0.01% |
| Dec. 12, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 6947 | $120.31 | 29,521.0000 | 98,900,000 | 19.05% | 0.01% |
| Dec. 12, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Non-Qualified Stock Option | 6978 | $81.05 | 46,387.0000 | 98,900,000 | 13.08% | 0.01% |
| Dec. 12, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Non-Qualified Stock Option | 6947 | $81.05 | 39,440.0000 | 98,900,000 | 14.98% | 0.01% |
| Dec. 7, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 38722 | $77.81 | 68,243.0000 | 98,900,000 | 131.17% | 0.04% |
| Dec. 7, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 38722 | $120.37 | 29,521.0000 | 98,900,000 | 56.74% | 0.04% |
| Dec. 7, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 12742 | $77.81 | 42,263.0000 | 98,900,000 | 43.16% | 0.01% |
| Dec. 7, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 12742 | $120.37 | 29,521.0000 | 98,900,000 | 30.15% | 0.01% |
| Dec. 7, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 14140 | $79.02 | 43,661.0000 | 98,900,000 | 47.90% | 0.01% |
| Dec. 7, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 14140 | $120.37 | 29,521.0000 | 98,900,000 | 32.39% | 0.01% |
| Dec. 7, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 11775 | $81.05 | 41,296.0000 | 98,900,000 | 39.89% | 0.01% |
| Dec. 7, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 11775 | $120.37 | 29,521.0000 | 98,900,000 | 28.51% | 0.01% |
| Dec. 8, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 200 | $81.05 | 29,721.0000 | 98,900,000 | 0.68% | 0.00% |
| Dec. 8, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 200 | $120.16 | 29,521.0000 | 98,900,000 | 0.67% | 0.00% |
| Dec. 8, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 100 | $81.05 | 29,621.0000 | 98,900,000 | 0.34% | 0.00% |
| Dec. 8, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 100 | $120.00 | 29,521.0000 | 98,900,000 | 0.34% | 0.00% |
| Dec. 7, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Non-Qualified Stock Option | 38722 | $77.81 | 12,742.0000 | 98,900,000 | 75.24% | 0.04% |
| Dec. 7, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Non-Qualified Stock Option | 12742 | $77.81 | 0.0000 | 98,900,000 | 100.00% | 0.01% |
| Dec. 7, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Non-Qualified Stock Option | 14140 | $79.02 | 60,005.0000 | 98,900,000 | 19.07% | 0.01% |
| Dec. 7, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Non-Qualified Stock Option | 11775 | $81.05 | 53,665.0000 | 98,900,000 | 17.99% | 0.01% |
| Dec. 8, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Non-Qualified Stock Option | 200 | $81.05 | 53,465.0000 | 98,900,000 | 0.37% | 0.00% |
| Dec. 8, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Non-Qualified Stock Option | 100 | $81.05 | 53,365.0000 | 98,900,000 | 0.19% | 0.00% |
| Dec. 6, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Common Stock | 8396 | $77.81 | 37,917.0000 | 98,900,000 | 28.44% | 0.01% |
| Dec. 6, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 8396 | $120.03 | 29,521.0000 | 98,900,000 | 22.14% | 0.01% |
| Dec. 6, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | M | Non-Qualified Stock Option | 8396 | $77.81 | 51,464.0000 | 98,900,000 | 14.03% | 0.01% |
| Aug. 21, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 3198 | $107.38 | 29,521.0000 | 98,900,000 | 9.77% | 0.00% |
| June 8, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | ROBERTS EIRY | Director | A | Stock Options (right to buy) | 30474 | $0.00 | 30,474.0000 | 289,057,198 | 9999.99% | 0.01% |
| June 8, 2023 | AMICUS THERAPEUTICS, INC. | $FOLD | ROBERTS EIRY | Director | A | Common Stock | 8584 | $0.00 | 44,014.0000 | 289,057,198 | 24.23% | 0.00% |
| April 24, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 14400 | $103.48 | 26,644.0000 | 98,900,000 | 35.08% | 0.01% |
| Feb. 13, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | A | Restricted Stock Unit | 8453 | $0.00 | 8,453.0000 | 98,900,000 | 9999.99% | 0.01% |
| Feb. 13, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | A | Stock Option | 52532 | $0.00 | 52,532.0000 | 98,900,000 | 9999.99% | 0.05% |
| Feb. 7, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 12801 | $102.41 | 40,135.0000 | 98,900,000 | 24.18% | 0.01% |
| Feb. 8, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 980 | $104.16 | 41,015.0000 | 98,900,000 | 2.33% | 0.00% |
| Feb. 6, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 1121 | $105.80 | 27,176.0000 | 98,900,000 | 3.96% | 0.00% |
| Feb. 7, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 1623 | $102.35 | 28,638.0000 | 98,900,000 | 5.36% | 0.00% |
| Jan. 31, 2023 | NEUROCRINE BIOSCIENCES INC | $NBIX | ROBERTS EIRY | Chief Medical Officer | S | Common Stock | 1457 | $109.99 | 26,171.0000 | 98,900,000 | 5.27% | 0.00% |